We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement

Stay up to date on the topics that matter to you

Trending News

A scientist in a lab holding up a centrifuge tube.

Materials Follow the “Rule of Four” — But Scientists Don’t Know Why Yet

A white blood cell.

Promising Treatment Approach for Aggressive Leukemia Identified

T cells.

Immune Cells “Remember” the Pain of Newborn Injuries

Siblings' Rare Genetic Mutation Offers Clues for Type 1 Diabetes Therapy

Nerve Cells in the Human Neocortex Are Wired Differently Than in Mice

Mobilizing Microglia in the Fight Against Alzheimer’s Disease

News

Training the Immune System to Destroy Cure-Defying Mutant HIV

This study reveals the reason behind the failure of luring HIV out of hiding, and charts a therapeutic strategy to eradicate mutant HIV-infected cells.

Prognostic Test for E2F4 in Breast Cancer Developed

A gene signature in E2F4 has been identified which is predictive of estrogen receptor positive breast cancer.

Abcam Partners with A*STAR’s Institute of Molecular and Cell Biology

Abcam Partners with A*STAR’s Institute of Molecular and Cell Biology.

Horizon Discovery Group plc Acquires Haplogen Genomics GmbH

Strategic acquisition of high-throughput functional genomics platform aims to drive product development, revenue growth and enable broader market penetration.

How Bacteria Control Their Size

By monitoring thousands of individual bacteria scientists discovered how they maintain their size from generation to generation.

Bristol-Myers Squibb and Calibr Collaborate

Collaboration and license agreement focused on new treatment approaches for fibrotic diseases.

Quickly Tracing The Source Of Tainted Food

Technology can trace contaminated food to its source.

Gilead Sciences Announces Acquisition of Phenex’s FXR Program

Gilead will acquire Farnesoid X Receptor program for the treatment of liver diseases including nonalcoholic steatohepatitis (NASH).

Pfizer Acquires Redvax

Acquisition provides Pfizer with a preclinical CMV vaccine candidate.

SK Capital Makes Strategic Investment in Halo Pharmaceutical

Company partners with Halo Pharmaceutical to support their growth with additional resources and capital.

Advertisement

Advertisement

Decoratvive background images

Never miss a story

with the Breaking Science News daily newsletter